Partners - Modelis

Bring success to new drug discovery projects

We work closely with various partners on drug discovery projects to help find new cures for rare genetic diseases. Modelis’ research is high throughput. We leverage new technologies (CRISPR) to discover new treatments and bridge the gap from bench to bedside.

We partner with Pharmaceutical Companies, Venture Philanthropists, Genetic Sequencing Groups, and more.

PHARMACEUTICAL COMPANIES

Pharmaceutical Companies know that drug discovery is expensive, especially when Research and Development initiatives aren’t successful. Modelis’ enables your organization to rapidly repurpose existing or failed treatments to enhance your organizations offerings. We help your company expand into the rare disease space.

Repurpose

Do you have unused proprietary compounds? We will repurpose them for you.

Low Risk

The Modelis approach minimizes risk while maximizing the chances of human applications.

Fast

Our research methodology enables you to realize outcomes quickly.

VENTURE PHILANTHROPISTS

Modelis develops personalized drug discovery projects to identify new therapies for rare diseases. We work with families, and Patient Advocacy Groups (PAG’s) to positively impact the genetic diseases they care about most. We share in the upside so that both of our organizations can improve the lives of patients with genetic diseases. We bridge the gap between bench and bedside to improve patient care, and patient outcomes.

Transparency

Our partners are part of each step of the drug discovery process.

Insight

Venture Philanthropists become meaningful contributors to finding a cure.

Fast

Our research methodology enables you to realize outcomes quickly.

GENETIC SEQUENCING GROUPS

Modelis provides functional genetic testing services to quickly validate genetic variants. This provides more definite data to our patients while providing an early contact with venture philanthropists for new drug discovery projects.